Hiroshi Kotani
11PUBLICATIONS
34CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Nov 09, 2025
MET Enhances Amivantamab Binding to EGFR and Antibody-Dependent Cellular Toxicity.Shigeki Sato, Neval Yilmaz, Sachiko Arai
|Apr 16, 2025
CAR T cell-driven induction of iNOS in tumor-associated macrophages promotes CAR T cell resistance in B cell lymphoma.Marco Davila, Sae Bom Lee, Yun Pyo Kang
|Oct 25, 2024
Pembrolizumab efficacy in a tumor mutation burden-high glioblastoma patient: A case study and implications for precision oncology.Akihiro Nishiyama, Shigeki Sato, Hiroyuki Sakaguchi
|Jul 11, 2024
Dual inhibition of SUMOylation and MEK conquers MYC-expressing KRAS-mutant cancers by accumulating DNA damage.Hiroshi Kotani, Hiroko Oshima, Justin C Boucher
|Apr 01, 2022
Inhibition of EGFR and MEK surmounts entrectinib resistance in a brain metastasis model of NTRK1-rearranged tumor cells.Chiaki Suzuki, Akihiro Nishiyama, Sachiko Arai
Pageof 2
Frequent Collaborators
5 joint publications
Marco L Davila
4 joint publications
Xuefeng Wang
3 joint publications
Michael Jain
3 joint publications
Frederick Locke
2 joint publications
Seiji Yano
2 joint publications
Shinji Takeuchi
2 joint publications
Yun Pyo Kang
2 joint publications
Koji Fukuda
2 joint publications
Atsushi Tajima
2 joint publications
Akihiro Nishiyama